Population-Dynamics And Production Of Euphausiids. IV Euphausia-Krohni Nematoscelis-Megalops And Thysanoessa-Gregaria And 8 Rare Species In The North-Atlantic Ocean

Seasonal changes in the abundance, size and occurrence of furciliae of Euphausia krohni (Brandt), Nematoscelis megalops (G. O. Sars) and Thysanoessa gregaria G. O. Sars are described from samples taken at 10 m depth with the Continuous Plankton Recorder (CPR) over a period of 2 yr (January 1966 to December 1967) in the North Atlantic Ocean. E. krohni and T. gregaria were found to breed through most of the year but N. megalops bred only in spring and summer. Annual mean biomass was calculated directly from the data and production was estimated from published P:B ratios. The seasonal occurrences of E. brevis Hansen, E. hemigibba Hansen, E. mutica Hansen, E. tenera Hansen, Stylocheiron longicorne G. O. Sars, S. maximum Hansen, Thysanopoda acutifrons Holt and Tattershall and T. aequalis Hansen in the samples are described.

8. Validating the alliance "Agrostio-Stipion giganteae"

The alliance Agrostio-Stipion giganteae has remained invalid till now, because the various conditions for valid publication have not been simultaneously fulfilled across a relatively long number of works concerning the syntaxon and their subordinate associations.

Analysis of the footprint in school age of 8-10 years old

Biomechanical problems in children, is an important subject currently, existing controversy in different areas, for example, the majority of children have a flattened footprint, or the hypermobility joint is linked to a musculoskeletal pain. The objective of the study was to determine what kind of footprint is most frequent in school-age children (8-10 years) in the area of Plasencia. This was taken as a sign 50 children, of whom 28 were males and 22 females. All the subjects in the study underwent an assessment of footprint planted in static as well as an exploration of different parameters through inspection in a standing position (formula digital, rearfoot). The results show that excavated footprint is present in a 72% cases of the population, 16% was belonging to an excavated footprint in which we find a higher percentage of weight related.For the digital formula we find that the most common is the Egyptian foot by 40% of the cases and that the prevalence in the rearfoot, is a normal hindfoot. In relation with the hypermobility joint, we check that it is more common in girls and that none of them presents an association to musculoskeletal pain. As a future line we could establish a more comprehensive study with new techniques and valuingchild’s statics and dynamics, to have a more accurate study of the different variables in the sample population studied.

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid

The two major incretin hormones, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP), are currently being considered as prospective drug candidates for treatment of type 2 diabetes. Interest in these gut hormones was initially spurred by their potent insulinotropic activities, but a number of other antihyperglycaemic actions are now established. One of the foremost barriers in progressing GLP-1 and GIP to the clinic concerns their rapid degradation and inactivation by the ubiquitous enzyme, dipeptidyl peptidase IV (DPP IV). Here, we compare the DPP IV resistance and biological properties of Abu(8)/ Abu(2) (2-aminobutyric acid) substituted analogues of GLP-1 and GIP engineered to impart DPP IV resistance. Whereas (Abu(8))GLP-1 was completely stable to human plasma (half-life > 12h), GLP-1, GIP, and (Abu(2))GIP were rapidly degraded (half-lives: 6.2, 6.0, and 7.1 h, respectively). Native GIP, GLP-1, and particularly (Abu(8))GLP-1 elicited significant adenylate cyclase and insulinotropic activity, while (Abu(2))GIP was less effective. Similarly, in obese diabetic (ob/ob) mice, GIP, GLP-1, and (Abu(8))GLP-1 displayed substantial glucose-lowering and insulin -releasing activities, whereas (Abu(2))GIP was only weakly active. These studies illustrate divergent effects of penultimate amino acid Ala(8)/Ala(2) substitution with Abu on the biological properties of GLP-1 and GIP, suggesting that (Abu(8))GLP-1 represents a potential candidate for future therapeutic development. (C) 2004 Elsevier Inc. All rights reserved.